Differential activity and selectivity of N‐terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors - Archive ouverte HAL Access content directly
Journal Articles Journal of Leukocyte Biology Year : 2020

Differential activity and selectivity of N‐terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors

(1) , (2) , (1) , (1) , (3) , (4) , (5) , (3) , (3) , (1) , (6, 7)
1
2
3
4
5
6
7

Abstract

Chemokines play critical roles in numerous physiological and pathological processes through their action on seven-transmembrane (TM) receptors. The N-terminal domain of chemokines, which is a key determinant of signaling via its binding within a pocket formed by receptors' TM helices, can be the target of proteolytic processing. An illustrative case of this regulatory mechanism is the natural processing of CXCL12 that generates chemokine variants lacking the first two N-terminal residues. While such truncated variants behave as antagonists of CXCR4, the canonical G proteincoupled receptor of CXCL12, they are agonists of the atypical chemokine receptor 3 (ACKR3/
Fichier principal
Vignette du fichier
JaraczRosAgnieska_BaleuxFrancoise_LevoyeAngelique_2020.pdf (1.99 Mo) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

pasteur-03260272 , version 1 (14-06-2021)

Identifiers

Cite

Agnieszka Jaracz-Ros, Guillaume Bernadat, Pasquale Cutolo, Carmen Gallego, Martin Gustavsson, et al.. Differential activity and selectivity of N‐terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors. Journal of Leukocyte Biology, 2020, 107 (6), pp.1123 - 1135. ⟨10.1002/jlb.2ma0320-383rr⟩. ⟨pasteur-03260272⟩
37 View
37 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More